Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

First marketing approval granted for Vitrase in Mexico; U.S. phase III trials now under way

Nov. 24, 1998

Akorn announces U.S. market introduction for BioLon

Nov. 24, 1998

Latanoprost monotherapy is as effective as combination therapy in lowering IOP

Nov. 20, 1998

Three major studies support antiglaucoma efficacy of Cosopt

Nov. 19, 1998

Animal data suggest that GPI-1046 may be useful in glaucoma

Nov. 18, 1998

New prostaglandins with IOP-lowering effects disclosed by Santen and Asahi Glass

Nov. 16, 1998

Final results presented from phase II Vitrase trial

Nov. 13, 1998

Significant antiinflammatory activity seen with loteprednol etabonate in cataract surgery setting

Nov. 5, 1998

Vitrase to be fast-tracked by FDA

Oct. 16, 1998

Long-acting fluorine-containing prostaglandins for ocular diseases

Oct. 7, 1998